Dale Chappell Insider Trading $KBIO HUMANIGEN, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dale Chappell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dale Chappell. Dale Chappell is in HUMANIGEN, INC ($KBIO) and 10% Owner in HUMANIGEN, INC ($KBIO) and Chief Scientific Officer in HUMANIGEN, INC ($KBIO) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO).
Dale Chappell in HUMANIGEN, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dale Chappell: Chief Scientific Officer
Holdings: 1,057,826 shares
Current Value: $3,057,117
Latest Transaction: Jun 25 2021
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dale Chappell in HUMANIGEN, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 725,000 | 12,907,538 | 8,220,079 | 8.9 M to 8.2 M (-8.11 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 101,158 | 1,858,768 | 8,945,079 | 9 M to 8.9 M (-1.12 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 96,516 | 1,764,776 | 9,046,237 | 9.1 M to 9 M (-1.06 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 200,000 | 3,560,700 | 2,243,807 | 2.4 M to 2.2 M (-8.18 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 27,906 | 512,770 | 2,443,807 | 2.5 M to 2.4 M (-1.13 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 26,625 | 486,833 | 2,471,713 | 2.5 M to 2.5 M (-1.07 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 75,000 | 1,335,263 | 972,361 | 1 M to 972.4 K (-7.16 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 10,465 | 192,293 | 1,047,361 | 1.1 M to 1 M (-0.99 %) |
| Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 9,985 | 182,574 | 1,057,826 | 1.1 M to 1.1 M (-0.94 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 291,798 | 5,398,030 | 9,142,753 | 9.4 M to 9.1 M (-3.09 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 131,532 | 2,521,876 | 9,434,551 | 9.6 M to 9.4 M (-1.37 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.40 | 111,325 | 2,160,061 | 9,566,083 | 9.7 M to 9.6 M (-1.15 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 80,496 | 1,489,112 | 2,498,338 | 2.6 M to 2.5 M (-3.12 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 36,284 | 695,677 | 2,578,834 | 2.6 M to 2.6 M (-1.39 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.40 | 34,431 | 667,948 | 2,615,118 | 2.6 M to 2.6 M (-1.30 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 30,186 | 558,417 | 1,067,811 | 1.1 M to 1.1 M (-2.75 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 13,607 | 260,888 | 1,097,997 | 1.1 M to 1.1 M (-1.22 %) |
| Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.50 | 12,730 | 248,178 | 1,111,604 | 1.1 M to 1.1 M (-1.13 %) |
| Sep 22 2020 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Option Exercise | A | 9.65 | 133,760 | 1,290,784 | 133,760 | |
| Apr 07 2020 | KBIO | HUMANIGEN, INC | Chappell Dale | Buy | C | 0.36 | 1,583,333 | 570,000 | 49,636,917 | 48.1 M to 49.6 M (+3.29 %) | |
| Jun 04 2019 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 586,027 | 0 | 48,053,584 | 47.5 M to 48.1 M (+1.23 %) |
| Jun 04 2019 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 591,248 | 0 | 47,467,557 | 46.9 M to 47.5 M (+1.26 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | P | 0.09 | 32,028,669 | 3,001,086 | 46,876,309 | 14.8 M to 46.9 M (+215.72 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 12,812,322 | 0 | 14,847,640 | 2 M to 14.8 M (+629.50 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 11,957,369 | 0 | 13,997,832 | 2 M to 14 M (+586.01 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 5,123,733 | 0 | 5,996,710 | 873 K to 6 M (+586.93 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | P | 0.09 | 32,028,669 | 3,001,086 | 46,876,309 | 14.8 M to 46.9 M (+215.72 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 12,812,322 | 0 | 14,847,640 | 2 M to 14.8 M (+629.50 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 11,957,369 | 0 | 13,997,832 | 2 M to 14 M (+586.01 %) |
| Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 5,123,733 | 0 | 5,996,710 | 873 K to 6 M (+586.93 %) |
| Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Chappell Dale | Director | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 |
Page: 1